Quanterix (QTRX) Free Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | -20.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.14% |
| Dec 31, 2025 | -296.36% |
| Sep 30, 2025 | -791.61% |
| Jun 30, 2025 | 1.80% |
| Mar 31, 2025 | 26.73% |
| Dec 31, 2024 | 52.66% |
| Sep 30, 2024 | -51.56% |
| Jun 30, 2024 | -2,911.16% |
| Mar 31, 2024 | -107.30% |
| Dec 31, 2023 | -273.67% |
| Sep 30, 2023 | 84.21% |
| Jun 30, 2023 | 101.80% |
| Mar 31, 2023 | 56.82% |
| Dec 31, 2022 | 522.52% |
| Sep 30, 2022 | -5.01% |
| Jun 30, 2022 | 23.76% |
| Mar 31, 2022 | -62.97% |
| Dec 31, 2021 | -14.23% |
| Sep 30, 2021 | -174.33% |
| Jun 30, 2021 | -95.96% |
| Mar 31, 2021 | -6.68% |
| Dec 31, 2020 | 123.25% |
| Sep 30, 2020 | -773.24% |
| Jun 30, 2020 | 23.73% |
| Mar 31, 2020 | -17.85% |
| Dec 31, 2019 | 31.45% |
| Sep 30, 2019 | 111.90% |
| Jun 30, 2019 | -226.10% |
| Mar 31, 2019 | -7.23% |
| Dec 31, 2018 | -43.20% |
| Sep 30, 2018 | -5.20% |
| Jun 30, 2018 | 48.76% |
| Mar 31, 2018 | -158.14% |